Monday, June 11, 2018 1:29:09 PM
Any and all PPS analysis I have done is based solely on a best guess based on the comparable prices of similar oil and gas exploration companies, which there are not many of.
There are many more factors to be considered in order to provide a comprehensive PPS analysis, most of which cannot be calculated until there is actually an operating company that is producing hydrocarbons and selling them. Royalties to Israel and other factors are to be examined by professional analysts. Not me.
At the end of the day, it will be net earnings that determine the final PPS, and the markets view of the company and its probable and possible oil reserves.. I believe the designation for this is the P2.
The fact that ZN has no debt, and relatively few outstanding shares makes any discovery more meaningful on a per share basis than comparable companies. Any commercially viable discovery of oil more than a few hundred million BBL will be a game changer and propel Zion to a new horizon, a billion or more BBL would be an exponential game changer. Anything larger than 10 billion BBL and it’s anybody’a guess at this point.
I believe they found oil or gas and will be able to continue operating and generate earnings. That’s all any of us should expect as shareholders. If they find something amazing, then, well, it will be amazing to see what happens.
Recent ZNOG News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 07:38:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/26/2024 07:37:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 04:44:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/29/2024 04:43:39 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/25/2024 07:42:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 02:54:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:31:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 07:45:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:33:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:26:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:19:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:08:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 06:58:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 04:50:59 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/20/2023 04:49:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 07:38:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 05:43:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 02:38:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/06/2023 02:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 03:35:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 03:09:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 06:24:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/28/2023 09:02:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 05:40:34 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM